Biochemical Pharmacology
Overview
Biochemical Pharmacology is a peer-reviewed scientific journal that focuses on the molecular mechanisms of drug action and the biochemical basis of drug metabolism and disposition. It publishes original research articles, reviews, and perspectives in the field of pharmacology, providing valuable insights into the development and optimization of therapeutic interventions.
Details
Details
Abbr.
Biochem Pharmacol
Start
1958
End
Continuing
Frequency
Monthly, 2018-
p-ISSN
0006-2952
e-ISSN
1873-2968
Country
United Kingdom
Language
English
Specialties
Biochemistry
Pharmacology
Pharmacology
Metrics
Metrics
h-index / Ranks: 540
220
SJR / Ranks: 2276
1365
CiteScore / Ranks: 1502
9.80
JIF / Ranks: 1190
5.8
Recent Articles
1.
Hu Z, Xu D, Meng H, Liu W, Zheng Q, Wang J
Biochem Pharmacol
. 2025 Mar;
236:116853.
PMID: 40088723
No abstract available.
2.
Fang L, Li W, Zhao H, Wang W, Gao H, Wang P, et al.
Biochem Pharmacol
. 2025 Mar;
:116870.
PMID: 40086515
Steroid-induced avascular necrosis of the femoral head (SANFH) is a progressive degenerative disease of the hip, primarily due to glucocorticoid (GC)-induced endothelial cell (EC) injury and compromised blood supply. Irisin...
3.
Cordido A, Nunez-Gonzalez L, Lamas-Gonzalez O, Vizoso-Gonzalez M, Bravo S, Diaz C, et al.
Biochem Pharmacol
. 2025 Mar;
:116858.
PMID: 40081770
Autosomal Dominant and Autosomal Recessive Polycystic Kidney Disease (ADPKD and ARPKD) are, respectively, common and rare forms of polycystic disorders, characterized by the formation and progressive growth of cysts from...
4.
Yin Y, Cao Y, Zhou Y, Xu Z, Luo P, Yang B, et al.
Biochem Pharmacol
. 2025 Mar;
236:116869.
PMID: 40081769
Gilteritinib, a multi-target kinase inhibitor, is currently used as standard therapy for acute myeloid leukemia. However, approximately half of the patients encounter liver-related adverse effects during the treatment with gilteritinib,...
5.
Liu T, Zhuang X, Li Zhu X, Wu X, Juan Qin X, Bing Wei L, et al.
Biochem Pharmacol
. 2025 Mar;
:116867.
PMID: 40081768
Epigenetic changes are involved in many physiological and pathological processes. Mitophagy plays a critical role in chronic kidney disease (CKD); however, the role of N6-methyladenosine (m6A) modification in renal mitophagy...
6.
Gao Y, Liu X, Lv J, Gu C, Tao T, Zhang C, et al.
Biochem Pharmacol
. 2025 Mar;
:116851.
PMID: 40081767
Autoimmune toxicity affects up to 60 % of patients receiving immune checkpoint inhibitor (ICI) therapy for cancer, presenting a notable clinical obstacle that constrains its wider application. Hence, there is...
7.
Nguyen T, Pham D, Park P
Biochem Pharmacol
. 2025 Mar;
:116868.
PMID: 40081766
Mesenchymal stem cells (MSC) have been widely applied for regenerative medicine and the treatment of immune-disorders due to their multilineage differentiation and potent immunomodulatory properties. The therapeutic application of MSC...
8.
Paraschiakos T, Li J, Scholz J, Han S, Deckers M, Pogenberg V, et al.
Biochem Pharmacol
. 2025 Mar;
236:116866.
PMID: 40064451
Upregulation of the actin-severing protein Cofilin-1 is implicated in enhancing malignancy of various cancer types by promoting actin turnover and increasing cellular motility. Despite the importance of targeting Cofilin-1, currently...
9.
Zhao Q, Li H, Liu D, Zhou B, Gong C, Chen L, et al.
Biochem Pharmacol
. 2025 Mar;
236:116857.
PMID: 40058708
Atherosclerosis (AS) is a chronic inflammatory disease, and pyroptosis-a recently discovered pro-inflammatory programmed cell death process-can exacerbate these inflammatory responses. Vascular endothelial cell pyroptosis contributes to AS progression. Cathepsin B...
10.
Fang Y, Tan C, Zheng Z, Yang J, Tang J, Guo R, et al.
Biochem Pharmacol
. 2025 Mar;
236:116849.
PMID: 40056941
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignant tumor characterized by a poor prognosis. A prominent feature of PDAC is the rich and dense stroma present in the tumor...